305 related articles for article (PubMed ID: 30445002)
1. Reviewing two decades of nanomedicine implementations in targeted treatment and diagnosis of pancreatic cancer: An emphasis on state of art.
El-Zahaby SA; Elnaggar YSR; Abdallah OY
J Control Release; 2019 Jan; 293():21-35. PubMed ID: 30445002
[TBL] [Abstract][Full Text] [Related]
2. The new era of pancreatic cancer treatment: Application of nanotechnology breaking through bottlenecks.
Luo W; Zhang T
Cancer Lett; 2024 Jul; 594():216979. PubMed ID: 38795762
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer.
Li YJ; Wu JY; Wang JM; Xiang DX
J Control Release; 2020 Apr; 320():105-111. PubMed ID: 31978441
[TBL] [Abstract][Full Text] [Related]
5. Stromal barriers to nanomedicine penetration in the pancreatic tumor microenvironment.
Tanaka HY; Kano MR
Cancer Sci; 2018 Jul; 109(7):2085-2092. PubMed ID: 29737600
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine in Pancreatic Cancer: A New Hope for Treatment.
Redruello P; Perazzoli G; Cepero A; Quiñonero F; Mesas C; Doello K; Láinez-Ramos-Bossini A; Rivera-Izquierdo M; Melguizo C; Prados J
Curr Drug Targets; 2020; 21(15):1580-1592. PubMed ID: 32619168
[TBL] [Abstract][Full Text] [Related]
7. pH-sensitive nano-systems for drug delivery in cancer therapy.
Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
[TBL] [Abstract][Full Text] [Related]
8. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
Danhier F; Feron O; Préat V
J Control Release; 2010 Dec; 148(2):135-46. PubMed ID: 20797419
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicines Targeting the Tumor Microenvironment.
Tong R; Langer R
Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
[TBL] [Abstract][Full Text] [Related]
10. Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer.
Meng H; Nel AE
Adv Drug Deliv Rev; 2018 May; 130():50-57. PubMed ID: 29958925
[TBL] [Abstract][Full Text] [Related]
11. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.
Yang F; Jin C; Subedi S; Lee CL; Wang Q; Jiang Y; Li J; Di Y; Fu D
Cancer Treat Rev; 2012 Oct; 38(6):566-79. PubMed ID: 22655679
[TBL] [Abstract][Full Text] [Related]
12. Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force.
Wang Z; Zhi K; Ding Z; Sun Y; Li S; Li M; Pu K; Zou J
Semin Cancer Biol; 2021 Feb; 69():77-90. PubMed ID: 31962173
[TBL] [Abstract][Full Text] [Related]
13. Emerging therapeutic nanotechnologies in pancreatic cancer: advances, risks and challenges.
Rebelo A; Reis C
Ther Deliv; 2018 Oct; 9(10):691-694. PubMed ID: 30277137
[No Abstract] [Full Text] [Related]
14. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
15. Nanocarriers for anticancer drugs--new trends in nanomedicine.
Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnological carriers for cancer chemotherapy: the state of the art.
Estanqueiro M; Amaral MH; Conceição J; Sousa Lobo JM
Colloids Surf B Biointerfaces; 2015 Feb; 126():631-48. PubMed ID: 25591851
[TBL] [Abstract][Full Text] [Related]
17. Targeted drug delivery systems for pancreatic cancer.
Khare V; Alam N; Saneja A; Dubey RD; Gupta PN
J Biomed Nanotechnol; 2014 Dec; 10(12):3462-82. PubMed ID: 26000366
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnologies for noninvasive measurement of drug release.
Moore T; Chen H; Morrison R; Wang F; Anker JN; Alexis F
Mol Pharm; 2014 Jan; 11(1):24-39. PubMed ID: 24215280
[TBL] [Abstract][Full Text] [Related]
20. [The development of novel tumor targeting delivery strategy].
Gao HL; Jiang XG
Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]